Edition:
United Kingdom

Aurobindo Pharma Ltd (ARBN.NS)

ARBN.NS on National Stock Exchange of India

589.50INR
11:24am BST
Change (% chg)

Rs-10.75 (-1.79%)
Prev Close
Rs600.25
Open
Rs599.10
Day's High
Rs601.30
Day's Low
Rs587.40
Volume
1,292,240
Avg. Vol
3,006,596
52-wk High
Rs838.00
52-wk Low
Rs536.60

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2019 Mar '19 52,922.00 9.990
Dec 52,696.70 12.150
Sep 47,514.00 10.440
Jun 42,502.70 7.780
FY 2018 Mar '18 40,490.90 9.020
Dec 43,361.10 10.160
Sep 44,358.90 13.333
Jun 36,787.50 8.850
FY 2017 Mar '17 36,416.30 9.096
Dec 39,061.80 9.888
Sep 37,754.50 10.400
Jun 37,665.90 9.996
 
*Note: Units in Millions ofRupee
**Note: Units in Rupee

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Mar-19 18 51,197.50 54,498.80 48,675.00 --
Year Ending Mar-19 26 190,957.00 202,535.00 175,850.00 --
Year Ending Mar-20 15 262,189.00 281,760.00 250,381.00 200,393.00
Year Ending Mar-21 15 294,072.00 312,107.00 270,552.00 214,507.00
Earnings (per share)
Quarter Ending Mar-19 7 11.40 11.80 10.90 --
Year Ending Mar-19 28 42.76 45.30 37.00 --
Year Ending Mar-20 15 51.30 57.90 48.20 50.30
Year Ending Mar-21 15 57.86 64.60 48.90 51.48
LT Growth Rate (%) 2 12.63 16.10 9.16 12.03
Sales and Profit Figures in India Rupee (INR);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) 13.66 29.73 33.85
P/E High - Last 5 Yrs. 22.63 47.56 54.29
P/E Low - Last 5 Yrs. 13.49 27.30 28.22
Beta 0.77 1.00 0.99
Price to Sales (TTM) 1.65 6.00 7.90
Price to Book (MRQ) 2.32 3.84 4.38
Price to Tangible Book (MRQ) 2.99 4.14 5.07
Price to Cash Flow (TTM) 10.65 21.62 23.70
% Owned Institutions -- 0.79 1.78

Dividends

  Company industry sector
Dividend Yield 0.45 1.83 1.67
Dividend Yield - 5 Year Avg 0.36 1.47 1.37
Dividend 5 Year Growth Rate 10.76 6.74 6.82
Payout Ratio(TTM) 6.19 50.64 46.67

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago 30.70 13.42 14.65
Sales (TTM) vs TTM 1 Yr. Ago 18.57 6.45 8.45
Sales - 5 Yr. Growth Rate 19.29 8.32 9.43
EPS (MRQ) vs Qtr. 1 Yr. Ago 10.76 18.49 19.40
EPS (TTM) vs TTM 1 Yr. Ago -2.43 -- --
EPS - 5 Yr. Growth Rate 14.95 5.66 7.15
Capital Spending - 5 Yr. Growth Rate -- 7.02 8.01

Financial Strength

  Company industry sector
Quick Ratio (MRQ) 0.67 2.52 2.52
Current Ratio (MRQ) 1.28 3.55 3.52
LT Debt to Equity (MRQ) 1.30 11.64 12.61
Total Debt to Equity (MRQ) 60.58 16.17 17.64
Interest Coverage (TTM) 35.36 7.61 14.93

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 55.46 51.41 50.25
Gross Margin - 5 Yr. Avg. 51.87 50.53 51.36
EBITD Margin (TTM) 20.20 -- --
EBITD - 5 Yr. Avg 22.02 17.64 16.42
Operating Margin (TTM) 16.34 -2.19 -6.97
Operating Margin - 5 Yr. Avg. 18.83 13.94 11.87
Pre-Tax Margin (TTM) 15.80 -2.50 -7.30
Pre-Tax Margin - 5 Yr. Avg. 18.52 18.73 15.72
Net Profit Margin (TTM) 12.09 -6.21 -11.11
Net Profit Margin - 5 Yr. Avg. 13.83 14.06 11.11
Effective Tax Rate (TTM) 23.51 20.27 20.61
Effective Tax Rate - 5 Yr. Avg. 25.32 22.92 24.51

Efficiency

  Company industry sector
Revenue/Employee (TTM) -- 1,012,949,194 870,638,159
Net Income/Employee (TTM) -- 118,477,208 101,855,832
Receivable Turnover (TTM) 6.03 5.61 5.88
Inventory Turnover (TTM) 1.33 2.59 3.66
Asset Turnover (TTM) 0.82 0.88 0.85

Management Effectiveness

  Company industry sector
Return on Assets (TTM) 9.94 10.57 10.25
Return on Assets - 5 Yr. Avg. 12.71 11.70 11.17
Return on Investment (TTM) 17.62 13.04 12.69
Return on Investment - 5 Yr. Avg. 22.88 14.80 14.15
Return on Equity (TTM) 18.50 14.12 17.13
Return on Equity - 5 Yr. Avg. 25.13 15.92 15.53
  1 Year 3 Year 5 Year
Sales % 18.57 11.92 19.29
EPS (TTM) % -2.42 5.21 14.95
Dividend % 0.00 0.00 10.76
Note: Units in Millions of US Dollars

Performance for Aurobindo Pharma Ltd

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -7.33 -3.64 99 47
13 Week -32.21 -30.09 92 34
26 Week -28.33 -31.84 99 15
52 Week -3.25 -5.54 99 66
YTD -23.13 -26.81 99 20
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 24.02%
# of Holders: 182
Total Shares Held: 140,710,689
3 Mo. Net Change: -9,577,711
# New Positions: 4
# Closed Positions: 8
# Increased Positions: 42
# Reduced Positions: 52
# Net Buyers: -10
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.